1. Adachi JD, Loannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001; 12:903–908. PMID:
11804016.
Article
2. Bauss F, Dempster DW. Effects of ibandronate on bone quality : preclinical studies. Bone. 2007; 40:265–273. PMID:
16996333.
Article
3. Canpolat S, Tug N, Seyran AD, Kumru S, Yilmaz B. Effects of raloxifene and estradiol on bone turnover parameters in intact and ovariectomized rats. J Physiol Biochem. 2010; 66:23–28. PMID:
20428990.
Article
4. Ferretti M, Bertoni L, Cavani F, Zavatti M, Resca E, Carnevale G, et al. Influence of ferutinin on bone metabolism in ovariectomized rats. II : role in recovering osteoporosis. J Anat. 2010; 217:48–56. PMID:
20492429.
Article
5. French DL, Muir JM, Webber CE. The ovariectomized, mature rat model of postmenopausal osteoporosis : an assessment of the bone sparing effects of curcumin. Phytomedicine. 2008; 15:1069–1078. PMID:
18693096.
Article
6. Kim TH, Jung JW, Ha BG, Hong JM, Park EK, Kim HJ, et al. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss. J Nutr Biochem. 2011; 22:8–15. PMID:
20233653.
Article
7. Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parfitt AM. The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int. 1985; 37:594–597. PMID:
3937580.
Article
8. Lei Z, Xiaoying Z, Xingguo L. Ovariectomy-associated changes in bone mineral density and bone marrow haematopoiesis in rats. Int J Exp Pathol. 2009; 90:512–519. PMID:
19765105.
Article
9. Meli R, Pacilio M, Raso GM, Esposito E, Coppola A, Nasti A, et al. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology. 2004; 145:3115–3121. PMID:
15059958.
Article
10. Miller SC, Bowman BM, Jee WS. Available animal models of osteopenia--small and large. Bone. 1995; 17:117S–123S. PMID:
8579907.
11. Mosekilde L. Assessing bone quality--animal models in preclinical osteoporosis research. Bone. 1995; 17:343S–352S. PMID:
8579937.
12. Omi N, Ezawa I. The effect of ovariectomy on bone metabolism in rats. Bone. 1995; 17:163S–168S. PMID:
8579912.
Article
13. Palumbo C, Ferretti M, Bertoni L, Cavani F, Resca E, Casolari B, et al. Influence of ferutinin on bone metabolism in ovariectomized rats. I : role in preventing osteoporosis. J Bone Miner Metab. 2009; 27:538–545. PMID:
19333679.
Article
14. Park SB, Lee YJ, Chung CK. Bone mineral density changes after ovariectomy in rats as an osteopenic model : stepwise description of double dorso-lateral approach. J Korean Neurosurg Soc. 2010; 48:309–312. PMID:
21113356.
Article
15. Sheng ZF, Dai RC, Wu XP, Fang LN, Fan HJ, Liao EY. Regionally specific compensation for bone loss in the tibial trabeculae of estrogen-deficient rats. Acta Radiol. 2007; 48:531–539. PMID:
17520429.
Article
16. Shiraishi A, Miyabe S, Nakano T, Umakoshi Y, Ito M, Mihara M. The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis. BMC Musculoskelet Disord. 2009; 10:66. PMID:
19527501.
Article
17. Szulc P, Delmas PD. Biochemical markers of bone turnover : potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int. 2008; 19:1683–1704. PMID:
18629570.
Article
18. Thompson DD, Simmons HA, Pirie CM, Ke HZ. FDA Guidelines and animal models for osteoporosis. Bone. 1995; 17:125S–133S. PMID:
8579908.
Article
19. Turner AS. Animal models of osteoporosis--necessity and limitations. Eur Cell Mater. 2001; 1:66–81. PMID:
14562261.